Strategic Advisors LLC lessened its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) by 86.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,301 shares of the pharmacy operator’s stock after selling 63,199 shares during the period. Strategic Advisors LLC’s holdings in Walgreens Boots Alliance were worth $96,000 as of its most recent SEC filing.
A number of other hedge funds have also recently modified their holdings of the business. First Financial Corp IN boosted its stake in Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 885 shares in the last quarter. Golden State Wealth Management LLC bought a new position in Walgreens Boots Alliance in the 4th quarter worth about $26,000. TD Private Client Wealth LLC boosted its stake in Walgreens Boots Alliance by 8,670.3% in the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 3,208 shares in the last quarter. Sentry Investment Management LLC bought a new position in Walgreens Boots Alliance in the 3rd quarter worth about $30,000. Finally, Eastern Bank bought a new position in Walgreens Boots Alliance in the 3rd quarter worth about $33,000. Institutional investors own 58.59% of the company’s stock.
Wall Street Analysts Forecast Growth
WBA has been the topic of a number of analyst reports. Royal Bank of Canada upped their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research note on Wednesday, January 15th. Truist Financial dropped their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, January 31st. Evercore ISI boosted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research report on Monday, January 13th. Jefferies Financial Group decreased their target price on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research report on Wednesday, October 23rd. Finally, Bank of America boosted their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research report on Monday, January 13th. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $13.19.
Walgreens Boots Alliance Price Performance
NASDAQ WBA opened at $9.70 on Tuesday. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $22.47. The firm has a market capitalization of $8.38 billion, a P/E ratio of -0.95, a PEG ratio of 1.26 and a beta of 0.65. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The company has a 50-day moving average price of $10.31 and a 200-day moving average price of $9.72.
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last released its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating the consensus estimate of $0.38 by $0.13. The firm had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.66 EPS. Equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Recommended Stories
- Five stocks we like better than Walgreens Boots Alliance
- How to Invest in Insurance Companies: A Guide
- Airbnb’s Earnings: Sky High Results, Grounded Guidance?
- When to Sell a Stock for Profit or Loss
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
- Best Stocks Under $10.00
- Conflicting Signals: Tempus AI’s Stock Market Rally
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.